Thursday, November 20, 2025

Suzetrigine (Journavx) for adults with moderate to severe acute pain

Two experts in treating pain at MUSC Health are looking forward to the arrival of a new non-opioid pain medication next month. The Food and Drug Administration has approved the use of suzetrigine (Journavx) for adults with moderate to severe acute pain, the kind a person would feel after surgery or an injury.  

No comments: